Phil Hui1, Deborah J Cook2, Wendy Lim3, Graeme A Fraser4, Donald M Arnold5. 1. Department of Medicine, Hamilton, ON, Canada. Electronic address: philip.hui@medportal.ca. 2. Department of Medicine, Hamilton, ON, Canada; Department of Clinical Epidemiology and Biostatistics, Hamilton, ON, Canada. 3. Department of Medicine, Hamilton, ON, Canada. 4. Department of Oncology, McMaster University, Hamilton, ON, Canada. 5. Department of Medicine, Hamilton, ON, Canada; Department of Clinical Epidemiology and Biostatistics, Hamilton, ON, Canada; Canadian Blood Services, Hamilton, ON, Canada.
Abstract
BACKGROUND: The epidemiology of thrombocytopenia in critically ill patients has not been well characterized. The objective of this study was to systematically review the prevalence, incidence, and consequences of, and risk factors for, thrombocytopenia among critically ill patients. METHODS: We searched MEDLINE, EMBASE, the Cochrane Registry for controlled trials (until May 2010), and the Online Computer Library, as well as bibliographies of relevant studies, to identify investigations designed to examine the frequency, risk factors, and/or outcomes associated with thrombocytopenia among patients admitted to the ICU. We independently selected studies, abstracted data, and assessed methodologic quality in duplicate. Heterogeneity of design and analysis precluded statistical pooling of results. RESULTS: We identified 24 studies (12 prospective) enrolling 6,894 patients from medical, surgical, mixed, or trauma ICUs. Prevalent thrombocytopenia (on ICU admission) occurred in 8.3% to 67.6% of patients; incident thrombocytopenia (developing during the course of the ICU stay) occurred in 13.0% to 44.1% of patients. High illness severity, sepsis, and organ dysfunction often correlated with thrombocytopenia. Only one study using multivariate analysis examined whether thrombocytopenia was associated with major bleeding, but it found no association. Six out of eight studies using multivariate analysis found that thrombocytopenia increased the risk of death. CONCLUSIONS: The frequency of thrombocytopenia during critical illness varies widely, based on case mix and definition. After confounding factors are adjusted for, thrombocytopenia appears to increase the risk of death.
BACKGROUND: The epidemiology of thrombocytopenia in critically illpatients has not been well characterized. The objective of this study was to systematically review the prevalence, incidence, and consequences of, and risk factors for, thrombocytopenia among critically illpatients. METHODS: We searched MEDLINE, EMBASE, the Cochrane Registry for controlled trials (until May 2010), and the Online Computer Library, as well as bibliographies of relevant studies, to identify investigations designed to examine the frequency, risk factors, and/or outcomes associated with thrombocytopenia among patients admitted to the ICU. We independently selected studies, abstracted data, and assessed methodologic quality in duplicate. Heterogeneity of design and analysis precluded statistical pooling of results. RESULTS: We identified 24 studies (12 prospective) enrolling 6,894 patients from medical, surgical, mixed, or trauma ICUs. Prevalent thrombocytopenia (on ICU admission) occurred in 8.3% to 67.6% of patients; incident thrombocytopenia (developing during the course of the ICU stay) occurred in 13.0% to 44.1% of patients. High illness severity, sepsis, and organ dysfunction often correlated with thrombocytopenia. Only one study using multivariate analysis examined whether thrombocytopenia was associated with major bleeding, but it found no association. Six out of eight studies using multivariate analysis found that thrombocytopenia increased the risk of death. CONCLUSIONS: The frequency of thrombocytopenia during critical illness varies widely, based on case mix and definition. After confounding factors are adjusted for, thrombocytopenia appears to increase the risk of death.
Authors: Gang Zheng; Michael B Streiff; Clifford M Takemoto; Jennifer Bynum; Elise Gelwan; Jayesh Jani; Danielle Judge; Thomas S Kickler Journal: Clin Appl Thromb Hemost Date: 2017-08-04 Impact factor: 2.389
Authors: Christos Perisanidis; Martina Mittlböck; Alexandra Schoppmann; Gabriela Kornek; Patrick Starlinger; Anton Stift; Edgar Selzer; Christian Schopper; Rolf Ewers Journal: Clin Oral Investig Date: 2012-05-29 Impact factor: 3.573
Authors: Jörn A Karhausen; Alan M Smeltz; Igor Akushevich; Mary Cooter; Mihai V Podgoreanu; Mark Stafford-Smith; Susan M Martinelli; Manuel L Fontes; Miklos D Kertai Journal: Anesth Analg Date: 2017-10 Impact factor: 5.108
Authors: Z Sheng; H Zhao; H Yan; S Jiang; Y Guan; Y Zhang; L Song; C Liu; P Zhou; K Liu; J Liu; Y Tan Journal: Herz Date: 2017-07-19 Impact factor: 1.443
Authors: Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman Journal: Am J Respir Cell Mol Biol Date: 2018-07 Impact factor: 6.914